InChI=1S/C45H66O16/c1-9-10-11-12-13-14-37(49)59-41-29(21-39(51)56-8)20-32-24-35(27(2)46)58-40(52)23-30(47)22-33-25-36(48)43(5,6)44(53,60-33)26-34-18-28(19-38(50)55-7)17-31(57-34)15-16-42(3,4)45(41,54)61-32/h11-16,19,21,27,30-36,41,46-48,53-54H,9-10,17-18,20,22-26H2,1-8H3/b12-11+,14-13+,16-15+,28-19+,29-21+/t27-,30-,31+,32+,33-,34+,35-,36+,41+,44+,45-/m1/s1 |
LIPGUSBNMQRYNL-IZBIBDMISA-N |
C/1(\C[C@H]2O[C@@H](C1)C[C@]3(C([C@H](C[C@@H](C[C@H](CC(O[C@@H]([C@@H](C)O)C[C@@]4(C\C(\[C@@H]([C@](C(C=C2)(C)C)(O4)O)OC(/C=C/C=C/CCC)=O)=C/C(OC)=O)[H])=O)O)O3)O)(C)C)O)=C\C(OC)=O |
|
Bugula neritina
(NCBI:txid10212)
|
See:
J. Nat. Prod., 1983, v46, 528-531
|
protein kinase C agonist
An agonist that selectively binds to and activates a protein kinase C receptor
marine metabolite
Any metabolite produced during a metabolic reaction in marine macro- and microorganisms.
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
(1S,3S,5Z,7R,8E,11S,12S,13E,15S,17R,21R,23R,25S)-1,11,21,25-tetrahydroxy-17-[(1R)-1-hydroxyethyl]-5,13-bis(2-methoxy-2-oxoethylidene)-10,10,26,26-tetramethyl-19-oxo-18,27,28,29-tetraoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-12-yl (2E,4E)-octa-2,4-dienoate
|
(+)-bryostatin 2
|
ChEBI
|
7-O-deacetylbryostatin 1
|
ChemIDplus
|
8306043
|
Reaxys Registry Number
|
Reaxys
|
87745-28-6
|
CAS Registry Number
|
ChemIDplus
|
1904062
|
PubMed citation
|
Europe PMC
|
2334938
|
PubMed citation
|
Europe PMC
|
2720677
|
PubMed citation
|
Europe PMC
|
2910827
|
PubMed citation
|
Europe PMC
|
|